Russell Barton is Chief Operating Officer of Acumen Pharmaceuticals, Inc.. Currently has a direct ownership of 123,269 shares of ABOS, which is worth approximately $219,418. The most recent transaction as insider was on Jan 08, 2026, when has been sold 3,530 shares (Common Stock) at a price of $1.86 per share, resulting in proceeds of $6,565. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 123K
9.44% 3M change
11.34% 12M change
Total Value Held $219,418

Russell Barton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 08 2026
SELL
Open market or private sale
$6,565 $1.86 p/Share
3,530 Reduced 2.78%
123,269 Common Stock
Jan 07 2026
SELL
Open market or private sale
$3,383 $1.99 p/Share
1,700 Reduced 1.32%
126,799 Common Stock
Jan 06 2026
SELL
Open market or private sale
$7,127 $1.97 p/Share
3,618 Reduced 2.74%
128,499 Common Stock
Jan 05 2026
SELL
Open market or private sale
$7,840 $1.96 p/Share
4,000 Reduced 2.94%
132,117 Common Stock
Jan 21 2025
SELL
Open market or private sale
$4,691 $1.61 p/Share
2,914 Reduced 2.1%
136,117 Common Stock
Jan 06 2025
BUY
Grant, award, or other acquisition
-
49,800 Added 26.37%
139,031 Common Stock
Jan 03 2025
SELL
Open market or private sale
$14,202 $1.86 p/Share
7,636 Reduced 7.88%
89,231 Common Stock
Jan 18 2024
SELL
Open market or private sale
$10,567 $3.73 p/Share
2,833 Reduced 2.84%
96,867 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
73,000 Added 42.27%
99,700 Common Stock
Jan 17 2023
BUY
Grant, award, or other acquisition
-
26,700 Added 50.0%
26,700 Common Stock
RB

Russell Barton

Chief Operating Officer
Charlottesville, VA

Track Institutional and Insider Activities on ABOS

Follow Acumen Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABOS shares.

Notify only if

Insider Trading

Get notified when an Acumen Pharmaceuticals, Inc. insider buys or sells ABOS shares.

Notify only if

News

Receive news related to Acumen Pharmaceuticals, Inc.

Track Activities on ABOS